SF3B1 and cancer: Percentages of cryptic transcripts versus canonical transcripts were quantified in primary material from genotyped CLL (Supplemental Table S3), MDS (Supplemental Table S4) and UM (Supplemental Table S5), and in cancer cell lines from different origin -/+ SF3B1 mutation (Figures 2B, C, respectively).